PharmacoEconomics & Outcomes News

, Volume 807, Issue 1, pp 36–36 | Cite as

PHARMAC changes funding for Gaucher's disease therapy

News item


  1. PHARMAC. Decision to widen access and change the funded enzyme replacement therapy for Gaucher disease. Internet Document : 6 Jul 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations